By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > Markets > Stocks > EPAM Systems downgraded at several firms after a surprise guidance cut
Stocks

EPAM Systems downgraded at several firms after a surprise guidance cut

News Room
Last updated: 2023/06/08 at 2:07 AM
By News Room
Share
2 Min Read
SHARE

© Reuters. EPAM Systems downgraded at several films after a surprise guidance cut

EPAM Systems Inc (NYSE:) was downgraded at five Wall Street firms after the company lowered its Q2/23 and full-year guidance due to further deterioration in the near-term demand environment, which resulted in a share price drop of more than 21% on Monday.

Q2 revenues are now expected to be in the range of $1.1- $1.17 billion (2.5% year-over-year decrease at the midpoint), while full-year revenues are now seen at $4.65-$4.80B (2% year-over-year decrease at the midpoint).

Citi downgraded the company to Neutral from Buy and cut its price target to $220.00 from $310.00, noting that both the magnitude and timing of the update surprised them.

The bank lowered its estimates on EPAM on a softer client spending environment, slower pipeline conversions, and delayed client decision-making.

Barclays downgraded the company to Equalweight from Overweight and cuts its price target to $220.00 from $310.00 as they believe macro-related headwinds, headcount re-calibration, and uncertainty from the Russia/Ukraine conflict will continue to pressure the stock in the near term.

While the firm made the decision to move to the sidelines, it believes that EPAM’s management team is capable of reinvigorating growth once the macro environment turns more positive.

Meanwhile, BofA Securities downgraded the company to Underperform from Buy and cut its price target to $223.00 from $310.00. According to the bank, recent quarters have seen management credibility take a hit, and while the latest guide seems potentially de-risked, they believe yesterday’s update tips EPAM into being more of “show me” story.

Read the full article here

News Room June 8, 2023 June 8, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Quanex Building Products Corporation (NX) Q4 2025 Earnings Call Transcript

FollowQ4: 2025-12-11 Earnings SummaryEPS of $0.83 beats by $0.31  | Revenue of $489.85M…

Europe’s rocky relations with Donald Trump

Gideon talks to Jens Stoltenberg, Nato's former secretary-general, about Ukraine and Europe's…

Why One Income No Longer Pays For The American Dream

Watch full video on YouTube

Crypto founder Do Kwon sentenced to 15 years in prison

Stay informed with free updatesSimply sign up to the Cryptocurrencies myFT Digest…

Peter Thiel just cashed out of Nvidia. 💸

Watch full video on YouTube

- Advertisement -
Ad imageAd image

You Might Also Like

Stocks

CPS reports solid 2023 performance, eyes future growth By Investing.com

By News Room
Stocks

Niu Technologies faces mixed results in Q4 2023 By Investing.com

By News Room
Stocks

Exagen Inc. reports strong 2023 revenue growth By Investing.com

By News Room
Stocks

Legacy Housing reports mixed results amid sales decline By Investing.com

By News Room
Stocks

Harmony Biosciences exec sells over $383k in stock By Investing.com

By News Room
Stocks

Biofrontera posts record revenue and outlines growth plans By Investing.com

By News Room
Stocks

Granite Ridge CFO buys $31,000 in company stock By Investing.com

By News Room
Stocks

Coliseum Capital Management buys MasterCraft Boat shares worth over $3.2m By Investing.com

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?